secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicine Man Technologies, Inc. (—)
CIK:        0001622879
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001104659-24-062075
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Schwazze Q1 revenue up 4% to $41.6M but net loss of $16.1M; Adjusted EBITDA down 49% YoY
--------------------------------------------------------------------------------

- Revenue of $41.6M, up 4% YoY; gross margin fell to 43.1% from 54.6% on pricing pressure.
- Net loss of $16.1M vs net income of $1.7M in Q1 2023.
- Adjusted EBITDA of $7.3M, down 49% from $14.5M a year ago.
- Cash and equivalents $13.2M at quarter-end; total debt $159.7M.
- Company cites competitive retail environments in Colorado and New Mexico as headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924062075/0001104659-24-062075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924062075/tm2414632d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer